Obstetrics/Gynecology
RSSArticles
-
Vaginal Estrogen Found to Be Safe, Effective Option During Menopause
Results of recent research indicate that vaginal estrogen is effective and safe for the treatment of genitourinary symptoms. Such low-dose vaginal estrogen options keep blood levels within the normal postmenopausal range.
-
Condoms: Report Showcases Usage Trends
A recent analysis of national data indicates that from 2011-2015, 23.8% of women and 33.7% of men ages 15-44 used a condom at last sexual intercourse. Of those who used condoms, about 60% of men and 56% of women relied on condoms alone for pregnancy prevention.
-
More Parents Choosing the HPV Shot for Teens
Six of 10 U.S. parents now are choosing to have their teens vaccinated against HPV.
-
Postpartum Placement of Hormonal IUD Does Not Affect Breastfeeding Outcomes
Women can avoid unintended pregnancy and successfully breastfeed.
-
Subclinical Hypothyroidism: What Is It and When Should We Treat It?
The current diagnosis and treatment of subclinical hypothyroidism in women of reproductive age is controversial and may well change as new studies become available.
-
Antenatal Steroids for Very Early PTB
A large European multicenter study has shown that antenatal corticosteroid administration in patients at risk for imminent very early preterm birth (24 to 31 weeks) will decrease perinatal mortality and morbidity substantially, even after only three hours of exposure.
-
Irritable Bowel Syndrome, Constipation, and Quality of Life in Women
Irritable bowel syndrome has a negative effect on women’s quality of life and affects one-third of women who present for care with fecal incontinence.
-
Do Antibiotics Reduce Hormonal Contraceptive Effectiveness?
This is a systematic review of studies evaluating the effect of concomitant non-rifamycin antibiotic use on hormonal contraceptive effectiveness. Although data are limited, there is no evidence to support the existence of drug interactions.
-
Contraceptive Research: Science Heads to New Frontiers
Funding recently has been awarded to scientists around the globe through the Grand Challenges Explorations program, an initiative funded by the Bill & Melinda Gates Foundation. The program seeks to foster concepts for contraceptive discovery platforms that can contribute to the development of new methods suitable for women and men living in limited resource settings.
-
Increased Focus on Preventing Preeclampsia
Cases of preeclampsia in the United States have increased since 1980 from 2.4% of all pregnancies to 3.8% in 2010. This increase is cause for concern: Preeclampsia accounts for more than $2.18 billion of the healthcare expenditure in the first 12 months after birth.